Swedbank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113M | Sell |
254,347
-35,727
| -12% | -$15.9M | 0.13% | 133 |
|
|
2025
Q1 | $141M | Sell |
290,074
-166,513
| -36% | -$80.7M | 0.19% | 105 |
|
|
2024
Q4 | $184M | Sell |
456,587
-121,926
| -21% | -$49.1M | 0.23% | 92 |
|
|
2024
Q3 | $269M | Sell |
578,513
-87,699
| -13% | -$40.8M | 0.34% | 66 |
|
|
2024
Q2 | $312M | Buy |
+666,212
| New | +$312M | 0.42% | 49 |
|
|
2024
Q1 | – | Sell |
-664,034
| Closed | -$270M | – | 709 |
|
|
2023
Q4 | $270M | Sell |
664,034
-9,223
| -1% | -$3.75M | 0.44% | 47 |
|
|
2023
Q3 | $234M | Buy |
673,257
+57,839
| +9% | +$20.1M | 0.41% | 48 |
|
|
2023
Q2 | $217M | Sell |
615,418
-15,682
| -2% | -$5.52M | 0.37% | 52 |
|
|
2023
Q1 | $199M | Sell |
631,100
-6,346
| -1% | -$2M | 0.39% | 55 |
|
|
2022
Q4 | $184M | Buy |
637,446
+4,932
| +0.8% | +$1.42M | 0.4% | 54 |
|
|
2022
Q3 | $183M | Sell |
632,514
-49,384
| -7% | -$14.3M | 0.43% | 49 |
|
|
2022
Q2 | $192M | Sell |
681,898
-6,790
| -1% | -$1.91M | 0.43% | 53 |
|
|
2022
Q1 | $180M | Buy |
688,688
+24,532
| +4% | +$6.4M | 0.33% | 65 |
|
|
2021
Q4 | $148M | Buy |
664,156
+8,960
| +1% | +$1.99M | 0.25% | 85 |
|
|
2021
Q3 | $119M | Buy |
655,196
+43,410
| +7% | +$7.87M | 0.22% | 98 |
|
|
2021
Q2 | $123M | Buy |
611,786
+52,853
| +9% | +$10.7M | 0.23% | 100 |
|
|
2021
Q1 | $120M | Buy |
558,933
+121,997
| +28% | +$26.2M | 0.25% | 93 |
|
|
2020
Q4 | $102M | Buy |
+436,936
| New | +$102M | 0.3% | 102 |
|